SLAS Discovery
High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2
October 10, 2020
SLAS Discovery reports how scientists develop and use novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease. The journal focuses on drug discovery sciences with a strong record of scientific rigor and impact, reporting on research that:
SLAS Discovery’s Editorial Scope includes: scientific and technical advances in target identification/validation (including chemical probes, RNA silencing, gene editing technologies); biomarker discovery; assay development; virtual, medium- or high-throughput screening (biochemical and biological, biophysical, phenotypic, toxicological, ADME); lead generation/ optimization; chemical biology; informatics (data analysis, image analysis, statistics, bio- and chemo-informatics); review articles on target biology, new paradigms in drug discovery and advances in drug discovery technologies
Publishes: annually in January, February, March, April, June, July, August, September, October and December
SLAS is pleased to announce the awardees of the annual publication awards honoring articles and authors from 2020 published editions of SLAS Discovery.
SLAS Discovery
October 10, 2020
SLAS Discovery
October 4, 2016
SLAS Discovery
April 1, 1999